Literature DB >> 23236095

Revocation of Community Treatment Orders in a mental health service network.

Nicholas Owens1, Lisa Brophy.   

Abstract

OBJECTIVE: Community Treatment Orders (CTOs) require patients to co-operate with involuntary treatment in the community or risk having their CTO revoked and being readmitted to hospital. CTOs are used frequently in Australia. Their revocation has been under-investigated but is important because of the significant impact this process has on patients, families/carers and service-providers. This paper reports on an investigation of CTO revocations in a Victorian area mental health service in the period 2008-2010.
METHOD: This was a mixed-methods study involving extraction of data from the Victorian statewide clinical database, a file audit and semi-structured group interviews with key stakeholders. Two different time periods were compared.
RESULTS: CTOs are commonly revoked within three months of discharge from the inpatient unit and multiple service-providers and family/carers have varying involvement that appears to depend on the timing of the referral to the Crisis Assessment and Treatment Team.
CONCLUSIONS: The study identified opportunities for improving policy and practice, particularly in relation to reducing the amount of coercion experienced by people on CTOs and improving flexibility of service delivery.

Entities:  

Mesh:

Year:  2012        PMID: 23236095     DOI: 10.1177/1039856212470504

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  2 in total

Review 1.  Care planning for consumers on community treatment orders: an integrative literature review.

Authors:  Suzanne Dawson; Sharon Lawn; Alan Simpson; Eimear Muir-Cochrane
Journal:  BMC Psychiatry       Date:  2016-11-10       Impact factor: 3.630

2.  Carer involvement in compulsory out-patient psychiatric care in England.

Authors:  Jorun Rugkåsa; Krysia Canvin
Journal:  BMC Health Serv Res       Date:  2017-11-21       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.